Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
19.0%
% of HRTS's 42 holdings also in THNR
30.8%
% of THNR's 26 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus THNR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in HRTS |
Weight in THNR |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 8.7% | 16.4% | 8.7% | |
MERCK & CO. INC. | 3.5% | 5.2% | 3.5% | |
CHUGAI PHARMACEUTICAL CO LTD | 3.1% | 5.1% | 3.1% | |
THERMO FISHER SCIENTIFIC INC | 3.0% | 5.5% | 3.0% | |
AMGEN INC | 2.7% | 5.1% | 2.7% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to THNR
UNITEDHEALTH GROUP INC | 6.1% | |
NOVO NORDISK A/S-B | 4.2% | |
BRIDGEBIO PHARMA, INC. | 4.2% | |
ASTRAZENECA PLC | 3.8% | |
ROCHE HOLDINGS LTD-SPONS ADR | 3.4% | |
VERTEX PHARMACEUTICALS INC | 3.3% | |
ABBOTT LABORATORIES | 3.0% | |
BOSTON SCIENTIFIC CORP | 2.9% | |
CYTOKINETICS INC | 2.8% | |
MEDTRONIC PLC | 2.5% |
HRTS Underweight Relative to THNR
NOVO-NORDISK A/S-SPONS ADR | -12.7% | |
ELI LILLY & CO | -7.6% | |
PFIZER INC | -5.6% | |
ROCHE HOLDING LTD | -5.4% | |
ASTRAZENECA PLC-SPONS ADR | -5.3% | |
TEVA PHARMACEUTICAL-SP ADR | -4.5% | |
FUJIFILM HOLDINGS CORP | -4.3% | |
MERCK KGAA | -3.6% | |
INNOVENT BIOLOGICS, INC. | -3.0% | |
MITSUBISHI CHEMICAL HOLDINGS | -3.0% |